Skip to main content
OpenTrials
Completed

NCT Number: NCT07240506

Effect of Caffeinated Chewing Gum on Vertical Jump Performance in Female Volleyball Players

This study aimed to examine the acute effects of caffeine intake through caffeinated chewing gum on the vertical jump performance of professional female volleyball players. Ten athletes from the Turkish Women's Volleyball First League voluntarily participated in this single-blind, placebo-controlled, randomized crossover study. Each athlete completed two test sessions: one with caffeinated gum containing 200 mg of caffeine and one with a caffeine-free placebo gum. After chewing the gum for 5 minutes, participants performed three types of vertical jump tests: squat jump, countermovement jump, and block jump. The results showed that caffeinated gum significantly improved countermovement jump height compared with the placebo, while no significant differences were observed for squat or block jumps. The findings suggest that caffeine in gum form may enhance explosive performance in sports requiring rapid power output, such as volleyball.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–33 year

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Yeşilyurt Sports Club - Women's Volleyball Team Training Facility

Istanbul, Bakırköy, 34149, Turkey (Türkiye)

About this study

Caffeine is a well-established ergogenic aid known to improve endurance, strength, and cognitive performance. However, limited evidence exists on its acute effects in female team-sport athletes. This study was designed to evaluate the impact of acute caffeine intake via caffeinated chewing gum on vertical jump performance among professional female volleyball players. The research employed a randomized, single-blind, placebo-controlled crossover design.

Ten professional athletes aged 18-33 years from the Yeşilyurt Sports Club Women's A Team, competing in the Turkish Volleyball Federation Women's 1st League, were included. Participants underwent two experimental sessions: one involving caffeinated gum (CAF, 200 mg total caffeine from two 100 mg pieces) and one involving placebo gum (PLA, identical but caffeine-free), separated by a six-day washout period. The gums were chewed for 5 minutes, and jump performance tests were conducted 15 minutes later.

Vertical jump performance was evaluated using a Chronojump jump mat for three jump types: squat jump (SJ), countermovement jump (CMJ), and block jump (BJ). Each test included three attempts, with the highest score recorded for analysis. Data were analyzed with paired-sample t-tests using SPSS 27.0, with significance set at p<0.05.

The results showed that caffeine gum significantly increased CMJ height compared with the placebo (p<0.05), but no significant effects were observed for SJ or BJ performance. The findings indicate that caffeine in gum form may acutely improve explosive performance involving stretch-shortening cycle movements.

The study was approved by the Non-Interventional Clinical Research Ethics Committee of Istanbul Medipol University (Approval No: E-10840098-202.3.02-735). All participants provided informed consent prior to data collection.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Self-identified female athletes aged 18-33 years Professional volleyball players actively competing in the Turkish Women's Volleyball First League Minimum of 3 years of competitive volleyball experience Healthy individuals without any diagnosed medical conditions Willing to abstain from caffeine-containing products for at least 24 hours before each testing session Voluntarily agreed to participate and provided written informed consent

Exclusion criteria

Known cardiovascular, metabolic, or neurological disorders Current use of medications or supplements affecting physical performance or caffeine metabolism Pregnancy or breastfeeding History of caffeine sensitivity, intolerance, or allergy Failure to comply with pre-test instructions (e.g., caffeine restriction, rest period) Musculoskeletal injuries preventing full jump performance

Treatment and study plan

Caffeinated chewing gum

Dietary Supplement

Two pieces of caffeinated chewing gum providing 200 mg total caffeine; administered 15 minutes before performance testing.

Placebo chewing gum

Dietary Supplement

Two pieces of placebo chewing gum identical in appearance and flavor to the caffeinated gum but containing no caffeine; administered 15 minutes before performance testing.

Primary outcomes

  1. Countermovement Jump Height

    Time frame: Within 15 minutes after gum administration.

    Change in countermovement jump (CMJ) height measured using a Chronojump contact mat following caffeine or placebo gum ingestion.

Secondary outcomes

  1. Squat Jump Height

    Time frame: Within 15 minutes after gum administration.

    Change in squat jump (SJ) height measured using a Chronojump contact mat after caffeine or placebo gum ingestion.

  2. Block Jump Height

    Time frame: Within 15 minutes after gum administration.

    Change in block jump (BJ) height measured using a Chronojump contact mat after caffeine or placebo gum ingestion.

Sponsors and collaborators

Lead sponsor

Muttalip Ayar

Other

Registry information

Official study title

Effect of Acute Caffeine Intake Via Caffeinated Gum on Vertical Jump Performance in Female Volleyball Players: A Single-Blind Placebo-Controlled Trial

Acronym: CAF-GUM

Important dates

Study start
2025
Primary completion
2025
Study completion
2025
First posted
Nov 21, 2025
Registry last updated
Nov 28, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.